Predicting survival in pulmonary arterial hypertension: time to move forward [Editorial] (2010)
- Authors:
- Autor USP: SOUZA, ROGÉRIO DE - FM
- Unidade: FM
- Subjects: HIPERTENSÃO PULMONAR; ARTÉRIA PULMONAR (FISIOPATOLOGIA); PROGNÓSTICO
- Language: Inglês
- Imprenta:
- Publisher place: Copenhagen
- Date published: 2010
- Source:
- Título: European respiratory journal
- ISSN: 0903-1936
- Volume/Número/Paginação/Ano: v. 35, n. 5, p. 958-959, 2010
-
ABNT
PROVENCHER, S. e SOUZA, R. Predicting survival in pulmonary arterial hypertension: time to move forward [Editorial]. European respiratory journal. Copenhagen: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://erj.ersjournals.com/content/35/5/958.full.pdf+html. Acesso em: 06 maio 2026. , 2010 -
APA
Provencher, S., & Souza, R. (2010). Predicting survival in pulmonary arterial hypertension: time to move forward [Editorial]. European respiratory journal. Copenhagen: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://erj.ersjournals.com/content/35/5/958.full.pdf+html -
NLM
Provencher S, Souza R. Predicting survival in pulmonary arterial hypertension: time to move forward [Editorial] [Internet]. European respiratory journal. 2010 ; 35( 5): 958-959.[citado 2026 maio 06 ] Available from: http://erj.ersjournals.com/content/35/5/958.full.pdf+html -
Vancouver
Provencher S, Souza R. Predicting survival in pulmonary arterial hypertension: time to move forward [Editorial] [Internet]. European respiratory journal. 2010 ; 35( 5): 958-959.[citado 2026 maio 06 ] Available from: http://erj.ersjournals.com/content/35/5/958.full.pdf+html - Incidência de hematomas subdurais espontâneos em casos de pacientes com hipertensão arterial pulmonar: Análise de um registro de cinco anos
- Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. [Carta]
- Pulmonary hypertension in sickle cell disease
- Challenging the concept of adding more drugs in pulmonary arterial hypertension [Editorial]
- Pulmonary arterialhHypertension-related morbidity is prognostic for mortality
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
- RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study
- 2016 – Um segundo passo [Editorial]
- Building the Future of Trial Design in PAH on Solid Ground
- Goal-oriented treatment of pulmonary arterial hypertension
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
